Dina is a Partner on the Private Equity team at OrbiMed, which she joined in 2023. She has been active in healthcare private equity and venture capital investing since 2001.
Prior to OrbiMed, she worked at Omega Funds and NeoMed, and previously held investment roles at 3i Group and Index Ventures.
Dina holds a B.A. in Natural Sciences from the University of Cambridge and a Ph.D. in Molecular and Cellular Biology from Université Pierre et Marie Curie (Paris VI). She is also a CFA charterholder.